Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ailitong ointment
- Development stage
- Phase 4
- Lead developer
- Guangdong Provincial Administration of Traditional Chinese Medicine
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Ailitong ointment is an externally applied medication currently under investigation for the treatment of cancer pain. Its mechanism of action is being studied, with research focusing on its effects based on NGS gene polymorphism. It is associated with institutions involved in Traditional Chinese Medicine.
- Other names
- Ailitong癌理通膏
Beyond the preview
Go deeper on Ailitong ointment.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ailitong ointment.